Madiha Derouazi

Director Técnico/Científico/I+D en AC IMMUNE SA .

Fortuna: 7 271 $ al 30/04/2024

51 años

Health Technology

Consumer Services

Cargos activos de Madiha Derouazi

Empresas	Cargo	Inicio	Fin
AC IMMUNE SA	Director Técnico/Científico/I+D	01/01/2024	-
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Director/Miembro de la Junta	03/09/2012	-
	Director Ejecutivo	03/09/2012	-
	Fundador	03/09/2012	-

Empresas	Cargo	Inicio	Fin

Technical University of Berlin	Graduate Degree
Swiss Federal Institute of Technology	Doctorate Degree

Internacional

Suiza	3
Alemania	3

Operativa

Sectorial

Health Technology	3
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
AC IMMUNE SA	Health Technology

Empresas privadas	1
Amal Therapeutics SA Amal Therapeutics SA BiotechnologyHealth Technology Amal Therapeutics SA engages in the development of peptide-based therapeutic cancer vaccines. It offers KISMA, a novel peptide/protein-based immunization technology platform, which is self-adjuvanting and enables the assembly within one chimeric fusion protein of elements essential to generate potent immunity. The company was founded by Madiha Derouazi on September 3, 2012 and is headquartered in Geneva, Switzerland.	Health Technology

Empresas privadas

Health Technology